Altis Biosystems

Altis Biosystems develops advanced cell-based assays that bridge the gap between preclinical research and clinical translation. They provide researchers with reliable and predictive tools that accurately recapitulate human biology, enabling faster and more efficient drug discovery and development. They've developed RepliGut® Systems, a series of human primary intestinal epithelial cell model systems that recreate the gastrointestinal cell barrier. Representing multiple regions of the gut, these models deliver results that mimic in vivo response across a range of pharmacological applications including inflammation, toxicity, bioavailability, and barrier function.